Why Us

WE SEE OPPORTUNITY, NOT OBSTACLES

Next Generation Sequencing (NGS) testing is advancing faster than ever before. Compared to alternatives, NGS tests provide greater gene coverage, increasing the chance of detecting rare mutations. NGS also provides a cost-effective process for testing multiple genes, often leading to valuable clinical insights. The expansion of NGS testing, however, presents two significant challenges for clinical labs – handling the massive volume of data, reporting, and compliance requirements, and managing the complexity of interpreting results from large gene panels. The PierianDx solution solves both of those problems.

WE TACKLE COMPLEXITY AND SCALABILITY HEAD ON

Imagine one solution for enabling your Precision Medicine program that includes a full range of software, support and services. Imagine one space your clinical lab can access that includes a streamlined workflow, an extensive curated knowledgebase, comprehensive analysis, insightful interpretation, and precise reporting. That’s PierianDx’s Clinical Genomics WorkSpace (CGW) – a complete suite of solution modules accompanied by support services that provide a data-driven ecosystem for clinical labs to launch or expand their NGS testing programs.



Our Services

Comprehensive Platform. Flexible Engagement Model.

PierianDx offers the right mix of software, service and support to accelerate your precision medicine program.

cgw
ngs
pro

CLINICAL GENOMICS WORKSPACE (CGW)

Streamlined Integrated Workflow

The Clinical Genomics WorkSpace (CGW) is our comprehensive environment that will accelerate your ability to offer Next Generation Sequencing-based clinical tests. Our cloud-based single workspace solution seamlessly manages data and clinical workflow for each patient case.

Learn More


WE HAVE ACTIONABLE INTELLIGENCE

PierianDx’s KnowledgeSpace is the most powerful genomic data engine in the industry, delivering Actionable Intelligence at the point of care. Our constantly expanding molecular medical knowledgebase facilitates effective, data-driven, reproducible clinical decision-making.

WE SHARE AND SHARE ALIKE

Sharing is a pillar of the Clinical Genomics WorkSpace solution. From best practices for clinical assay development and validated computational pipelines to variant classifications and clinical interpretations, we believe that everyone benefits from shared insights. Our platform is designed to facilitate sharing among members in our network while protecting patient privacy and your intellectual property.



WE DELIVER VALUE – WHERE IT COUNTS

PierianDx CGW offers compelling value for any clinical lab seeking to build a successful NGS testing capability:

Streamlined Integrated Workflow

  • No human intervention is needed from initiating sequencing run to receiving draft clinical report

  • Single solution for analysis, classification, interpretation, and reporting replaces patchwork solutions

  • Integration into EMR via industry standard HL7 and API interfaces

  • Economic efficiencies gained, errors reduced, and genomic testing throughput increased

Summarizing Relevant, Clinically Actionable Data

  • Data from dozens of sources aggregated, organized into discrete data sets, and kept up-to-date in the PierianDx Knowledgebase

  • Human curation of medical knowledgebase (weekly updates)

  • Proprietary learning algorithm highlights the most relevant information for each patient

  • Clinical interpretations and variant classification frequencies from medical director peers for the same variants

  • Reporting tool facilitates deeper data review and rich editing of draft report

Control Patient and Variant Data

  • Maintain control of patient variant data critical for integrating treatments and outcomes

  • Leverage longitudinal information critical for effective future diagnosis and treatment


  • “Being able to better analyze DNA and genetic markers through PierianDx’s products will help us improve our patient-centered care, including diagnosis and treatment. Through sharing clinical interpretations, we expect to gain meaningful insights that could lead to better patient outcomes.”

    Anthony Magliocco, M.D., Department Chair of Pathology at Moffitt